Matches in Nanopublications for { ?s ?p "[BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP612069.RAvKgHln-BYf1I_5NV6TszmEPeGbhe7uPHr_2GzCks60M130_assertion description "[BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612069.RAvKgHln-BYf1I_5NV6TszmEPeGbhe7uPHr_2GzCks60M130_provenance.
- assertion description "[BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.